Glucagon-like Peptide Receptor Agonists (GLP-1 receptor agonists): A Powerful Addition to Foundational Therapy Kidney Care in Patients with Type 2 Diabetes Mellitus. Can Diabetes Endocrinol Today [Internet]. 25 nov. 2024 [cité 7 sept. 2026];2(3):31–35. Disponible à: https://CanadianDiabetesAndEndocrinologyToday.com/article/view/2-3-Girard